Inclusion Complexation of Lorazepam with Different Cyclodextrins Suitable for Parenteral Use-Reference-Cited by-同舟云学术

Inclusion Complexation of Lorazepam with Different Cyclodextrins Suitable for Parenteral Use

Published:2005-01 Issue:6 Volume:31 Page:567-575
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Holvoet Chantal,Vander Heyden Yvan,Plaizier-Vercammen Jacqueline

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.1080/03639040500214738

Reference29 articles.

1. AHFS, American Hospital Formulary Service (2002). Gerald, K. (Ed.). Drug Information. BethesdaMD, USA: American Society of Health-system Pharmacists, 2395–2396.

2. Study on the inclusion complexes of bromazepam with β- and β-hydroxypropyl-cyclodextrins

3. Effect of organic cosolvent‐induced skeletal muscle damage on the bioavailability of intramuscular [14C]diazepam

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancement of Solubility of Albendazole by Inclusion Complexation with Nanosponges and β-Cyclodextrin;Indian Journal of Pharmaceutical Education and Research;2024-03-06

2. Cholecalciferol complexation with hydroxypropyl-β-cyclodextrin (HPBCD) and its molecular dynamics simulation;Pharmaceutical Development and Technology;2022-04-21

3. 1,4-Benzodiazepines: Chemical stability and cyclodextrin solubilization;Journal of Drug Delivery Science and Technology;2021-12

4. Cyclodextrins in Parenteral Formulations;Journal of Pharmaceutical Sciences;2021-02

5. Experimental investigations, cytotoxicity and cellular uptake outcomes of physically modified duloxetine HCl inclusion complexes;Polymer Bulletin;2019-01-28